US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects ...

When Dennis Carr learned he had early Alzheimer’s disease, he immediately thought of his older brother who had died of the ...

SGLT2 inhibitors and dulaglutide are associated with comparable risk for dementia; however, it is uncertain whether these findings generalize to newer GLP-1 RAs.

On today’s edition of Sunrise Spotlight, News 40’s Ashlee Wilson sits down with Kayla Goodman with Massey Springs Senior Living. Together, they talked about this year’s Walk to End Alzheimer’s, which ...

People living with dementia generally need more support from care providers than those without. It’s therefore extremely ...

Lilly said Japan is the second major market in which the drug has received approval, after the United States where it is sold ...

This briefing covers notable health news: the US is donating 1 million mpox vaccine doses to Africa, AstraZeneca’s breast ...

Eli Lilly's Kisunla (donanemab) has been approved in Japan for early symptomatic Alzheimer's, including mild cognitive ...

A light-propelled spacecraft, infinitely recyclable plastic, and other inspiring projects earned trophies at this year's ...

Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs ...

A new analysis of classical medical texts suggests dementia was extremely rare in ancient Greece and Rome 2,000 to 2,500 ...

Steve Waddell, the founder, president and CEO of Nasoni, recently landed a $2.58 million federal grant to integrate advanced ...